Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: Boroline Suthol Active Neem: Product will be applied on the affected areas or facial acne prone areas for consecutively 30 days in a time gap of 8-12 hours.
Study Duration 30 days
Ther
Sponsors
GD Pharmaceuticals Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy males & female subjects in the age group of 13-45 years (both age inclusive) 2. Subject has a valid proof of identity and age. 3. Subject has apparently healthy skin on the test area. 4. Subjects must have a facial acne score of 1.5 to 3.5 that will be clinically determined to be mild to moderate. 5. Subjects having 5-30 non-inflammatory and 5-20 inflammatory active lesions. No treatment for acne/facial in the past 1 month. 6. Subjects representing normal, oily, dry, and combination skin. 7. Subjects willing to give voluntary written informed consent. 8. Subjects willing to come for regular follow-up visits. 9. Subjects ready to follow instructions during the study period. 10. Subjects without any open wounds, cuts, abrasions, irritation symptoms on the test area. 11. Subject willing to perform UPT (for females only).
Exclusion criteria
Exclusion criteria: 1. Subjects with Known hypersensitivity to any of the study products or constituents. 2. Subjects having any significant pathology in the test area. 3.Dark spots and post-acne scars on the instrument measurement area. 4. Subjects with any kind of skin allergy, antecedents, or cutaneous disease which may influence the study results. 5. Subjects having topical or systemic treatment in the last month prior to participation in the study and during the study that could interfere with the study treatments/assessments. 6. Subject is Pregnant or Lactating. 7. Subject with any significant medical condition that would interfere with the participation in the trial. 8. Subjects participated in any other cosmetic or therapeutic trial or in a similar investigation. 9. Subject is having Scars, excessive terminal hair, or tattoos on the test area. 10. Any antifungal or antibiotic use 14 days prior to enrolment.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Effectiveness against AcneTimepoint: Day 0 Day 10 Day 20 Day 30 | — |
Primary
| Measure | Time frame |
|---|---|
| 1 Reduction in lesion 2 Reduction in pore size count 3 Improvement in skin texture 4 Skin brightness and overall appearance 5 Reduction in redness associated with acne 6 Reduction in size of inflammatory acne lesions 7 Improvement in existing comedones 8 Reduction in symptoms like burning itching stinging and tingling Timepoint: Day 0 Day 10 Day 20 Day 30 | — |
Countries
India
Contacts
Public ContactPurushotam Yadav
Auriga Research Private Limited
Outcome results
None listed